$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000107997323001327 Filed on September 28, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$660.0K	$690.0K	$2.990M
YoY Change	-23.83%
% of Gross Profit
Research & Development	$8.299K	$10.00K	$82.76K
YoY Change	-70.82%		-58.76%
% of Gross Profit
Depreciation & Amortization	$461.00	$0.00	$1.645K
YoY Change	39.7%		41.69%
% of Gross Profit
Operating Expenses	$675.0K	$690.0K	$3.157M
YoY Change	-24.6%		23.78%
Operating Profit	-$675.0K		-$3.157M
YoY Change	-24.6%		23.78%
Interest Expense	-$70.00K	$50.00K	-$30.00K
YoY Change	-368.25%		-109.95%
% of Operating Profit
Other Income/Expense, Net	-$70.53K		$32.55K
YoY Change	191.94%		-100.3%
Pretax Income	-$750.0K	-$680.0K	-$3.190M
YoY Change	-18.43%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$745.5K	-$680.0K	-$3.189M
YoY Change	-18.91%		-138.47%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02		-$0.07
Diluted Earnings Per Share	-$0.02	-$0.01	-$0.07
COMMON SHARES
Basic Shares Outstanding	48.70M shares	47.34M shares	45.04M shares
Diluted Shares Outstanding	48.62M shares		45.04M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.0K	$630.0K	$630.0K
YoY Change	-92.62%
Cash & Equivalents	$140.4K	$626.0K
Short-Term Investments
Other Short-Term Assets	$30.00K	$30.00K	$30.00K
YoY Change	-77.82%
Inventory
Prepaid Expenses	$16.28K	$16.79K
Receivables
Other Receivables
Total Short-Term Assets	$162.6K	$648.7K	$650.0K
YoY Change	-92.0%	-80.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.621M	$6.851M	$6.940M
YoY Change	134.58%	136.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$7.701M	$6.945M	$6.940M
YoY Change	127.74%	128.35%
TOTAL ASSETS
Total Short-Term Assets	$162.6K	$648.7K	$650.0K
Total Long-Term Assets	$7.701M	$6.945M	$6.940M
Total Assets	$7.863M	$7.594M	$7.590M
YoY Change	45.22%	19.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.270M	$680.0K	$680.0K
YoY Change	131.15%
Accrued Expenses	$80.00K	$80.00K	$80.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.418M	$1.617M	$1.620M
YoY Change	100.88%	-17.31%
LONG-TERM LIABILITIES
Long-Term Debt	$1.680M	$1.720M	$1.720M
YoY Change	-67.77%
Other Long-Term Liabilities	$10.00K	$30.00K	$30.00K
YoY Change	-92.43%
Total Long-Term Liabilities	$1.690M	$1.750M	$1.750M
YoY Change	-68.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.418M	$1.617M	$1.620M
Total Long-Term Liabilities	$1.690M	$1.750M	$1.750M
Total Liabilities	$4.115M	$3.362M	$3.400M
YoY Change	-37.16%	-53.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$128.0M	-$127.2M
YoY Change	2.41%	2.57%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.711M	$4.194M	$4.190M
YoY Change
Total Liabilities & Shareholders Equity	$7.863M	$7.594M	$7.590M
YoY Change	45.22%	19.39%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$745.5K	-$680.0K	-$3.189M
YoY Change	-18.91%		-138.47%
Depreciation, Depletion And Amortization	$461.00	$0.00	$1.645K
YoY Change	39.7%		41.69%
Cash From Operating Activities	-$395.4K	-$450.0K	-$2.929M
YoY Change	-69.95%		336.59%
INVESTING ACTIVITIES
Capital Expenditures	$164.4K	$1.160M	$3.557M
YoY Change	-49.05%		72.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$164.4K	-$1.160M	-$3.557M
YoY Change	-49.05%		72.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$74.24K	610.0K	$3.951M
YoY Change	-80.26%		135.6%
NET CHANGE
Cash From Operating Activities	-$395.4K	-450.0K	-$2.929M
Cash From Investing Activities	-$164.4K	-1.160M	-$3.557M
Cash From Financing Activities	$74.24K	610.0K	$3.951M
Net Change In Cash	-$485.6K	-1.000M	-$2.534M
YoY Change	-61.53%		140.03%
FREE CASH FLOW
Cash From Operating Activities	-$395.4K	-$450.0K	-$2.929M
Capital Expenditures	$164.4K	$1.160M	$3.557M
Free Cash Flow	-$559.9K	-$1.610M	-$6.486M
YoY Change	-65.83%		137.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023	bnet	Gain On Sale Of Domains GainOnSaleOfDomains		usd
CY2023	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary		usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	bnet	Modification Of Warrants ModificationOfWarrants		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2022	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
CY2023	bnet	Commissions On Sale Of Units CommissionsOnSaleOfUnits		usd
CY2022	bnet	Commissions On Sale Of Units CommissionsOnSaleOfUnits		usd
CY2023	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	bnet	Adjustment For Debt Modification AdjustmentForDebtModification		usd
CY2022	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable		usd
CY2023	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions		usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation		usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation		usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-19333
CY2023	dei	Entity Registrant Name EntityRegistrantName	BION ENVIRONMENTAL TECHNOLOGIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
CY2023	dei	City Area Code CityAreaCode	(516)
CY2023	dei	Local Phone Number LocalPhoneNumber	586-5643
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	46500000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48703905	shares
CY2023	dei	Auditor Firm AuditorFirmId	457
CY2022	dei	Auditor Name AuditorName	Eide Baily LLP
CY2022	dei	Auditor Firm AuditorFirmId	286
CY2023	dei	Auditor Name AuditorName	Haynie & Company
CY2023	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2022	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2023Q2	us-gaap	Cash Cash	625964	usd
CY2022Q2	us-gaap	Cash Cash	3160442	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16785	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	157550	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	648749	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3318992	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	93875	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145787	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6851009	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2895558	usd
CY2023Q2	us-gaap	Assets Assets	7593633	usd
CY2022Q2	us-gaap	Assets Assets	6360337	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	677137	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1360644	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	864781	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	594798	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	75000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1616916	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1955442	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29068	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128864	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1715970	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5170610	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3361954	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7254916	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044790	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43758820	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47340480	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43054511	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131935418	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123620046	usd
CY2023Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127236663	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124047548	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4194105	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-932152	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7593633	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6360337	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3072163	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2348324	usd
CY2023	us-gaap	Depreciation Depreciation	1645	usd
CY2022	us-gaap	Depreciation Depreciation	1161	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	82759	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	200691	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3156567	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2550176	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3156567	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2550176	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	5836	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	5625	usd
CY2023	bnet	Interests Expense InterestsExpense	38384	usd
CY2022	bnet	Interests Expense InterestsExpense	301659	usd
CY2022	bnet	Gain On Sale Of Domains GainOnSaleOfDomains	902490	usd
CY2022	bnet	Gain On Legal Dissolution Of Subsidiary GainOnLegalDissolutionOfSubsidiary	10234501	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32548	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10840957	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3189115	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8290781	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1544	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3189115	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8292325	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45038479	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45038479	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41962302	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41962302	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11406339	usd
CY2022	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	1736662	usd
CY2022	bnet	Commissions On Warrant Exercises CommissionsOnWarrantExercises	-18601	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	17711	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	27500	usd
CY2022	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	8337	usd
CY2022	bnet	Issuance Of Warrants For Warrants IssuanceOfWarrantsForWarrants	30000	usd
CY2022	bnet	Vesting Of Options For Services VestingOfOptionsForServices	419370	usd
CY2022	us-gaap	Profit Loss ProfitLoss	8290781	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2023	bnet	Sale Of Units Value SaleOfUnitsValue	1906230	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000	usd
CY2023	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	131335	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	130000	usd
CY2023	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	62563	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	186462	usd
CY2023	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	249744	usd
CY2023	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	-86400	usd
CY2023	bnet	Modification Of Warrants Noncash Comp ModificationOfWarrantsNoncashComp	154932	usd
CY2023	bnet	Modification Of Warrants Interest ModificationOfWarrantsInterest	72589	usd
CY2023	bnet	Debt Modification DebtModification	3507917	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3189115	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3189115	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	8290781	usd
CY2022	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary	10234501	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1645	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1161	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	38384	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	319523	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	249744	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	346846	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	130000	usd
CY2023	bnet	Modification Of Warrants ModificationOfWarrants	154932	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	62563	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-140765	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33501	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-879618	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	366629	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	27116	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16923	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	340000	usd
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	289200	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2928584	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-670785	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3557059	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2062155	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3557059	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2062155	usd
CY2023	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	3906230	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	131335	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1736662	usd
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	86400	usd
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	18601	usd
CY2022	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest	-41000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3951165	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1677061	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2534478	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1055879	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4216321	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2023	bnet	Adjustment For Debt Modification AdjustmentForDebtModification	3507917	usd
CY2023	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	186462	usd
CY2022	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	17711	usd
CY2023	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
CY2023	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	90000	usd
CY2022	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	190000	usd
CY2023	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	179984	usd
CY2022	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	32000	usd
CY2022	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	50145	usd
CY2023	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	220052	usd
CY2022	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	666375	usd
CY2023	bnet	Cattle Per Head CattlePerHead	300	decimal
CY2023	bnet	Tech Wastage TechWastage	1500	decimal
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	83275	usd
CY2023	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2023Q3	bnet	Purchase Order PurchaseOrder	50000	usd
CY2023	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	4182260	usd
CY2023	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	3962207	usd
CY2023	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	220053	usd
CY2023	bnet	Percentage Of Sustainable PercentageOfSustainable	0.295	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zrrdybjsh0P4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zas5Ocn712Ek">Concentrations of credit risk</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	594798	usd
CY2023	bnet	Description Of Kreider2 Poultry Project DescriptionOfKreider2PoultryProject	Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) (‘Kreider Renewable Energy Facility’ or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). Now that development of the Company’s Gen3Tech is being deployed, the Company has commenced discussions with KF regarding updating and amending the JV agreement and anticipates executing an amended joint venture agreement during 2023. During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA).
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8292000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3189000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10235000	usd
CY2023	bnet	Gain On Sale Of Domain Amount GainOnSaleOfDomainAmount	902000	usd
CY2023Q2	bnet	Working Capital WorkingCapital	968000	usd
CY2023	bnet	Reduction Of Debt ReductionOfDebt	3522000	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4038000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1737000	usd
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	86000	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	19000	usd
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000	usd
CY2023	bnet	Reduction Of Debt ReductionOfDebt	3522000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2892222	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6862916	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2905820	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11907	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10262	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6851009	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2895558	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	211984	usd
CY2023	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2023	us-gaap	Depreciation Depreciation	1645	usd
CY2022	us-gaap	Depreciation Depreciation	1161	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	864781	usd
CY2023	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
CY2022	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	41315986	shares
CY2023	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2022	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
CY2022	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	40611677	shares
CY2023	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	1983968	shares
CY2022	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	1350625	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45038479	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41962302	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zjS5DhvuK4J6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_z88B5NfuiPal">Use of estimates</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q2	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	15156	usd
CY2022Q2	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	13598	usd
CY2023Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	6847760	usd
CY2023Q2	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04	pure
CY2023	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2023	bnet	Former Employee Compensation FormerEmployeeCompensation	72500	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2023	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	179981	usd
CY2022	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	32000	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	3520000	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3522000	usd
CY2023	bnet	Reduction Of Additional Paid In Capital ReductionOfAdditionalPaidInCapital	14051	usd
CY2023	bnet	Redemption Of Convertible Preferred Stock RedemptionOfConvertiblePreferredStock	41000	usd
CY2023	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023	us-gaap	Payments For Commissions PaymentsForCommissions	86400	usd
CY2023	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	175114	shares
CY2023	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	175114	shares
CY2023	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	131335	usd
CY2023Q2	us-gaap	Share Price SharePrice	1.00
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	346230	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	22500000	shares
CY2023	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	175114	shares
CY2023	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	175114	shares
CY2023	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	131335	usd
CY2023Q1	bnet	Sharebased Compensation Granted SharebasedCompensationGranted	275000	shares
CY2023Q2	bnet	Sharebased Compensation Granted SharebasedCompensationGranted	500000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	250000	shares
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4429263	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	805000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12006600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M29D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5085659	usd
CY2022Q2	bnet	Compensation Increased CompensationIncreased	25000	usd
CY2021Q2	bnet	Exercise Bonus ExerciseBonus	0.75	pure
CY2021	bnet	Warrants Held By Trust Owned WarrantsHeldByTrustOwned	3000000	usd
CY2023Q2	bnet	Warrants And Rights Outstandings WarrantsAndRightsOutstandings	18438339	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	83275	usd
CY2023Q2	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2022Q2	bnet	Purchase Order PurchaseOrder	50000	usd
CY2023	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	4182260	usd
CY2023	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	3962207	usd
CY2023	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	220053	usd
CY2023	bnet	Interests Costs Incurred Capitalized InterestsCostsIncurredCapitalized	6103693	usd
CY2022Q1	bnet	Sale Of Domain Description SaleOfDomainDescription	the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2255802	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q2	bnet	Bank Account Hacked Amount BankAccountHackedAmount	75000	usd
CY2023Q2	bnet	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears	75000	usd
CY2023Q2	bnet	Operating Leases Future Minimum Payment Receivable In Three Years OperatingLeasesFutureMinimumPaymentReceivableInThreeYears	37500	usd
CY2023Q2	bnet	Undiscounted Cash Flow UndiscountedCashFlow	112500	usd
CY2023Q2	bnet	Less Imputed Interest LessImputedInterest	-8432	usd
CY2023Q2	bnet	Capital Lease Contingent Rental Payments Due CapitalLeaseContingentRentalPaymentsDue	104068	usd
CY2023Q2	bnet	Finance Leases Liability Current FinanceLeasesLiabilityCurrent	75000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	29068	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M29D
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-670000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1741000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-117000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	303000	usd
CY2023	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	9000	usd
CY2022	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	8000	usd
CY2023	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	733000	usd
CY2022	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	1229000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-45000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3281000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	39500000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8299000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8274000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5459000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5436000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000	usd
CY2023Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	338000	usd
CY2022Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	339000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1054000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1054000	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	66000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16148000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16443000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16148000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16443000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure

Files In Submission

Name	View Source	Status
bnet-20230630_def.xml	Edgar Link	unprocessable
0001079973-23-001327-index-headers.html	Edgar Link	pending
0001079973-23-001327-index.html	Edgar Link	pending
0001079973-23-001327.txt	Edgar Link	pending
0001079973-23-001327-xbrl.zip	Edgar Link	pending
bion_10k-063023.htm	Edgar Link	pending
bion_ex31x1.htm	Edgar Link	pending
bion_ex31x2.htm	Edgar Link	pending
bion_ex32x1.htm	Edgar Link	pending
bion_ex32x2.htm	Edgar Link	pending
bnet-20230630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
bnet-20230630_cal.xml	Edgar Link	unprocessable
bnet-20230630_pre.xml	Edgar Link	unprocessable
bnet-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bion_10k-063023_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q3 Form 10-K Financial Statement

#000107997323001327 Filed on September 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q3 Form 10-K Financial Statement

#000107997323001327 Filed on September 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet